212 related articles for article (PubMed ID: 11255826)
1. "Be smart, be safe, be sure". The revised Pregnancy Prevention Program for women on isotretinoin.
Perlman SE; Leach EE; Dominguez L; Ruszkowski AM; Rudy SJ
J Reprod Med; 2001 Feb; 46(2 Suppl):179-85. PubMed ID: 11255826
[TBL] [Abstract][Full Text] [Related]
2. Fetal exposure to isotretinoin-an international problem.
Garcia-Bournissen F; Tsur L; Goldstein LH; Staroselsky A; Avner M; Asrar F; Berkovitch M; Straface G; Koren G; De Santis M
Reprod Toxicol; 2008 Jan; 25(1):124-8. PubMed ID: 18077132
[TBL] [Abstract][Full Text] [Related]
3. Trends in adherence to a revised risk management program designed to decrease or eliminate isotretinoin-exposed pregnancies: evaluation of the accutane SMART program.
Brinker A; Kornegay C; Nourjah P
Arch Dermatol; 2005 May; 141(5):563-9. PubMed ID: 15897377
[TBL] [Abstract][Full Text] [Related]
4. Fetal exposure to oral isotretinoin: failure to comply with the Pregnancy Prevention Program.
Atanackovic G; Koren G
CMAJ; 1999 Jun; 160(12):1719-20. PubMed ID: 10410634
[No Abstract] [Full Text] [Related]
5. A survey of pregnant women using isotretinoin.
Robertson J; Polifka JE; Avner M; Chambers C; Delevan G; Koren G; Lavigne SV; Martinez LP; Miller RK; Carey JC
Birth Defects Res A Clin Mol Teratol; 2005 Nov; 73(11):881-7. PubMed ID: 16228976
[TBL] [Abstract][Full Text] [Related]
6. Young women taking isotretinoin still conceive. Role of physicians in preventing disaster.
Atanackovic G; Koren G
Can Fam Physician; 1999 Feb; 45():289-92. PubMed ID: 10065298
[TBL] [Abstract][Full Text] [Related]
7. Compliance with pregnancy prevention measures during isotretinoin therapy.
Collins MK; Moreau JF; Opel D; Swan J; Prevost N; Hastings M; Bimla Schwarz E; Korb Ferris L
J Am Acad Dermatol; 2014 Jan; 70(1):55-9. PubMed ID: 24157382
[TBL] [Abstract][Full Text] [Related]
8. Accutane-exposed pregnancies--California, 1999.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2000 Jan; 49(2):28-31. PubMed ID: 10680601
[TBL] [Abstract][Full Text] [Related]
9. Potential subversion of pregnancy prevention program in the managed care setting.
Wilkin JK
Arch Dermatol; 1997 Feb; 133(2):243-4. PubMed ID: 9041846
[No Abstract] [Full Text] [Related]
10. A pregnancy-prevention program in women of childbearing age receiving isotretinoin.
Mitchell AA; Van Bennekom CM; Louik C
N Engl J Med; 1995 Jul; 333(2):101-6. PubMed ID: 7777014
[TBL] [Abstract][Full Text] [Related]
11. Caring for women with childbearing potential taking teratogenic dermatologic drugs. Guidelines for practice.
Perlman SE; Rudy SJ; Pinto C; Townsend-Akpan C
J Reprod Med; 2001 Feb; 46(2 Suppl):153-61. PubMed ID: 11255823
[TBL] [Abstract][Full Text] [Related]
12. [Isotretinoin (Roaccutane) in women of childbearing age: failure of following prescription guidelines].
Autret E; Radal M; Jonville-Béra AP; Goehrs JM
Ann Dermatol Venereol; 1997; 124(8):518-22. PubMed ID: 9740842
[TBL] [Abstract][Full Text] [Related]
13. Isotretinoin exposure and pregnancy outcome: an observational study of the Berlin Institute for Clinical Teratology and Drug Risk Assessment in Pregnancy.
Schaefer C; Meister R; Weber-Schoendorfer C
Arch Gynecol Obstet; 2010 Feb; 281(2):221-7. PubMed ID: 19444462
[TBL] [Abstract][Full Text] [Related]
14. Pregnancy prevention among women taking isotretinoin: failure to comply with the recommendations.
Boucher N; Beaulac-Baillargeon L
Can Fam Physician; 2006 Mar; 52(3):338-9. PubMed ID: 16926960
[TBL] [Abstract][Full Text] [Related]
15. Oral isotretinoin: prescribers beware.
Shear NH
CMAJ; 1999 Jun; 160(12):1723-4. PubMed ID: 10410636
[No Abstract] [Full Text] [Related]
16. We Pledge to Change iPLEDGE.
Pierson JC; Ferris LK; Schwarz EB
JAMA Dermatol; 2015 Jul; 151(7):701-2. PubMed ID: 25853235
[No Abstract] [Full Text] [Related]
17. [Exposure to isotretinoin during pregnancy in France: 25 years of follow-up].
Rouzès A; Jonville-Béra AP
Therapie; 2014; 69(1):53-63. PubMed ID: 24698189
[TBL] [Abstract][Full Text] [Related]
18. Continued occurrence of Accutane-exposed pregnancies.
Honein MA; Paulozzi LJ; Erickson JD
Teratology; 2001 Sep; 64(3):142-7. PubMed ID: 11514944
[TBL] [Abstract][Full Text] [Related]
19. [Pregnancy after isotretinoin use].
Manders KC; de Vries LC; Roumen FJ
Ned Tijdschr Geneeskd; 2013; 157(41):A6567. PubMed ID: 24103139
[TBL] [Abstract][Full Text] [Related]
20. A comparative review of the isotretinoin pregnancy risk management programs across four continents.
Kovitwanichkanont T; Driscoll T
Int J Dermatol; 2018 Sep; 57(9):1035-1046. PubMed ID: 29508918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
